KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Assets (2016 - 2025)

Historic Return on Assets for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to 0.17%.

  • Eli Lilly's Return on Assets rose 600.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.15% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Eli Lilly reported Return on Assets of 0.17% as of Q3 2025, which was up 600.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Return on Assets registered a high of 0.17% during Q3 2025, and its lowest value of 0.03% during Q1 2021.
  • Over the past 5 years, Eli Lilly's median Return on Assets value was 0.12% (recorded in 2021), while the average stood at 0.11%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 1000bps in 2022, then crashed by -400bps in 2023.
  • Eli Lilly's Return on Assets (Quarter) stood at 0.12% in 2021, then rose by 12bps to 0.13% in 2022, then crashed by -33bps to 0.09% in 2023, then soared by 60bps to 0.14% in 2024, then increased by 24bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.15% for Q2 2025, and 0.13% during Q1 2025.